Microfluidic enrichment of plasma cells improves treatment of multiple myeloma

Cytogenetic alterations form the basis for risk stratification for multiple myeloma (MM) and guide the selection of therapy; however, current pathology assays performed on bone marrow samples can produce false‐negatives due to the unpredictable distribution and rarity of MM cells. Here, we report on...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Yunjing, Gao, Li, Luo, Xiaoqing, Chen, Yan, Kabeer, Mustafa H., Chen, Xuelian, Stucky, Andres, Loudon, William G., Li, Shengwen C., Zhang, Xi, Zhong, Jiang F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026869/
https://www.ncbi.nlm.nih.gov/pubmed/29638042
http://dx.doi.org/10.1002/1878-0261.12201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026869/
https://www.ncbi.nlm.nih.gov/pubmed/29638042
http://dx.doi.org/10.1002/1878-0261.12201

Ejemplares similares